PNNL has created and licensed a system that sniffs out trace levels of fentanyl, other drugs and explosives through the air.

Scientists are developing ways to detect previously unseen forms of fentanyl as well as other synthetic opioids known as nitazenes.

Scientists have developed a way to detect tiny amounts of hard-to-detect explosives more than eight feet away.

At a one-day summit on PNNL’s Richland campus, scientists and engineers gather to hear from leaders and learn to lead others.

Vigorous exercise burns fat more in males than in females, but the benefits of exercise are broad for both sexes.

Scientists have learned more about how to protect the insulin-producing cells that die in patients with Type 1 diabetes.

PNNL researchers helped identify a fragment from the SARS-CoV-2 virus that spurs severe illness.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

Scientists have opened a new view into the workings of the central nervous system, finding a diverse set of important molecules.

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.